Skip to main content

and
  1. Article

    Open Access

    Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France

    With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, su...

    Maria Claudia Addamiano, Camille Joannes, Leslie Fonquerne in BMC Public Health (2024)

  2. Article

    Open Access

    Access to information and oncofertility consultation for young women with breast cancer: a population-based study

    Non-menopausal women with breast cancer treated with chemotherapy are at intermediate risk of post-treatment amenorrhea and decreased fertility. Although they should receive appropriate information, studies un...

    Florian Martinet-Kosinski, Sébastien Lamy, Eric Bauvin in Scientific Reports (2023)

  3. No Access

    Article

    Primary care physicians and oncologists are partners in cancer announcement

    The primary care physician (PCP) is central to cancer patients’ management. Announcement of the diagnosis is a critical time for patients, even if they wish to be fully informed. The French National Cancer Pla...

    Marie-Eve Rougé Bugat, Christelle Omnes, Cyrille Delpierre in Supportive Care in Cancer (2016)

  4. No Access

    Article

    Guideline sheets on the side effects of anticancer drugs are useful for general practitioners

    General practitioners (GPs) are more and more involved in the treatment of cancer patients but feel not informed enough about anticancer treatments and associated side effects. Better communication with treatm...

    Marie-Eve Rouge-Bugat, Donia Lassoued, Joy Bacrie in Supportive Care in Cancer (2015)

  5. Article

    Open Access

    A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival

    Adherence to therapy has been established for years as a critical parameter for clinical benefit in medical oncology. This study aimed to assess, in the current practice, the influence of the socio-demographic...

    Cécile Borel, Sébastien Lamy, Gisèle Compaci, Christian Récher in BMC Cancer (2015)

  6. No Access

    Article

    Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

    Prostate cancer is an important disease in terms of economic implications because of its increasing incidence and health care costs. We assessed the direct costs of the clinical management of prostate cancer i...

    Laurent Molinier, Christel Castelli in The European Journal of Health Economics (2011)